160 related articles for article (PubMed ID: 16918492)
1. Determinants of specificity of factor xa interaction with its physiological inhibitors.
Rezaie AR
Mini Rev Med Chem; 2006 Aug; 6(8):859-65. PubMed ID: 16918492
[TBL] [Abstract][Full Text] [Related]
2. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory properties of the P1 Tyr variant of antithrombin.
Yang L; Manithody C; Qureshi SH; Rezaie AR
Biochemistry; 2010 Mar; 49(12):2680-6. PubMed ID: 20184328
[TBL] [Abstract][Full Text] [Related]
4. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
[TBL] [Abstract][Full Text] [Related]
5. Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.
Huang X; Swanson R; Broze GJ; Olson ST
J Biol Chem; 2008 Oct; 283(44):29770-83. PubMed ID: 18768472
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the protein Z-dependent protease inhibitor.
Han X; Fiehler R; Broze GJ
Blood; 2000 Nov; 96(9):3049-55. PubMed ID: 11049983
[TBL] [Abstract][Full Text] [Related]
8. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
Rezaie AR; Manithody C; Yang L
J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
[TBL] [Abstract][Full Text] [Related]
9. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
10. Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex.
Qureshi SH; Yang L; Manithody C; Rezaie AR
Biochemistry; 2009 Jun; 48(22):5034-41. PubMed ID: 19378973
[TBL] [Abstract][Full Text] [Related]
11. Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.
Yang L; Rezaie AR
J Biol Chem; 2013 May; 288(18):12692-8. PubMed ID: 23530052
[TBL] [Abstract][Full Text] [Related]
12. A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa).
Chandrasekaran V; Lee CJ; Lin P; Duke RE; Pedersen LG
J Mol Model; 2009 Aug; 15(8):897-911. PubMed ID: 19172319
[TBL] [Abstract][Full Text] [Related]
13. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
Mast AE; Broze GJ
Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
[TBL] [Abstract][Full Text] [Related]
14. Role of basic residues of the autolysis loop in the catalytic function of factor Xa.
Manithody C; Yang L; Rezaie AR
Biochemistry; 2002 May; 41(21):6780-8. PubMed ID: 12022882
[TBL] [Abstract][Full Text] [Related]
15. Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.
Ahnström J; Gierula M; Temenu J; Laffan MA; Lane DA
J Thromb Haemost; 2020 Jan; 18(1):136-150. PubMed ID: 31466141
[TBL] [Abstract][Full Text] [Related]
16. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
17. Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin.
Rezaie AR; Yang L
Biochim Biophys Acta; 2001 Oct; 1528(2-3):167-76. PubMed ID: 11687304
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
Rezaie AR
Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
[TBL] [Abstract][Full Text] [Related]
19. Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.
Huang X; Dementiev A; Olson ST; Gettins PG
J Biol Chem; 2010 Jun; 285(26):20399-409. PubMed ID: 20427285
[TBL] [Abstract][Full Text] [Related]
20. Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes.
Ho G; Broze GJ; Schwartz AL
J Biol Chem; 1997 Jul; 272(27):16838-44. PubMed ID: 9201990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
